The investment will establish drug product manufacturing capacity for clinical trial and commercial supply in China and offer customers combined drug substance and drug product manufacturing services
Cosentyx is a proven treatment, supported by long-term five-year sustained efficacy and safety data across several inflammatory conditions and with more than 500,000 patients treated worldwide since launch
The approval is based on a multi-centre, single-arm, open-label pivotal clinical trial
Phase II trial will evaluate the safety and efficacy of ASC40 in patients with moderate to severe acne
Arch Pharma Labs has filed the application
The expanded laboratories and manufacturing facilities at Nansha are expected to come online between Q1 2022 and Q3 2022
Capvaxive has recorded $530 million in cumulative sales over its first four quarters on the market
Sotyktu continues to demonstrate consistent efficacy and safety across rheumatic conditions
The company's net income attributable to equity holders dropped to €2.80 billion from €2.82 billion last year
INEOS production of BDO in Germany, which produces a vital ingredient for antibiotics, statins and vitamin B6, is being crushed by a flood of carbon heavy imports and product dumping from the Far East
Subscribe To Our Newsletter & Stay Updated
